Table 1 Baseline and cycle characteristics of the women in the RPL and control groups
RPL group | Control group | P-value | |
|---|---|---|---|
N = 131 | N = 126 | ||
Age (years) | 33.12 ± 4.75 | 33.00 ± 6.00 | 0.856 |
BMI | 22.16 ± 2.79 | 21.73 ± 3.10 | 0.126 |
No. of pregnancy losses | 3.14 ± 0.81 | 0.31 ± 0.67 | 0.000 |
E2 (pg/ml) | 40.59 ± 19.76 | 39.50 ± 17.58 | 0.644 |
T (ng/dL) | 43.71 ± 23.52 | 44.89 ± 24.85 | 0.694 |
Ovarian reserve | |||
AMH | 4.10 ± 3.23 | 3.95 ± 3.07 | 0.713 |
FSH on day 2 | 7.78 ± 2.60 | 7.97 ± 2.68 | 0.566 |
AFC | 10.39 ± 5.44 | 11.46 ± 6.24 | 0.143 |
Cycle and embryo characteristics | |||
Duration of stimulation | 9.39 ± 2.50 | 10.41 ± 3.03 | 0.003 |
Total dosage of gonadotropins | 26.43 ± 11.61 | 28.23 ± 12.72 | 0.218 |
Estradiol on trigger day (pmol/l) | 4337.26 ± 2130.30 | 4718.70 ± 2338.80 | 0.173 |
Mature oocytes (MII) retrieved | 8.68 ± 5.01 | 9.26 ± 5.30 | 0.366 |
Fertilized oocytes (2PN) | 7.86 ± 4.90 | 7.84 ± 5.07 | 0.977 |
No. of cleavage stage embryos | 6.07 ± 4.16 | 5.86 ± 4.36 | 0.686 |
No. of blastocysts | 3.05 ± 2.82 | 2.84 ± 2.23 | 0.521 |
No. of euploid blastocysts | 1.72 ± 1.78 | ||
No. of aneuploid blastocysts | 1.28 ± 1.39 | ||
No. of mosaic blastocysts | 0.05 ± 0.22 | ||